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Development of human genetics theoretical models and the integration of those
models with experiment and statistical evaluation are critical for scientific progress.
This perspective argues that increased effort in disease genetics theory, complementing
experimental, and statistical efforts, will escalate the unraveling of molecular etiologies
of complex diseases. In particular, the development of new, realistic disease genetics
models will help elucidate complex disease pathogenesis, and the predicted patterns in
genetic data made by these models will enable the concurrent, more comprehensive
statistical testing of multiple aspects of disease genetics predictions, thereby better
identifying disease loci. By theoretical human genetics, I intend to encompass all
investigations devoted to modeling the heritable architecture underlying disease traits
and studies of the resulting principles and dynamics of such models. Hence, the
scope of theoretical disease genetics work includes construction and analysis of models
describing how disease-predisposing alleles (1) arise, (2) are transmitted across families
and populations, and (3) interact with other risk and protective alleles across both
the genome and environmental factors to produce disease states. Theoretical work
improves insight into viable genetic models of diseases consistent with empirical results
from linkage, transmission, and association studies as well as population genetics.
Furthermore, understanding the patterns of genetic data expected under realistic disease
models will enable more powerful approaches to discover disease-predisposing alleles
and additional heritable factors important in common diseases. In spite of the pivotal role
of disease genetics theory, such investigation is not particularly vibrant.
Keywords: disease genetics, theoretical model, human genetics, GWAS (genome-wide association study),
complex diseases, statistical genetics and genomics
INTRODUCTION
Development of human genetics theoretical models and the integration of those models with
experiment and statistical evaluation are critical for scientific progress. This perspective argues that
increased effort in disease genetics theory, complementing experimental, and statistical efforts, will
escalate the unraveling of molecular etiologies of complex diseases. In particular, the development
of new, realistic disease genetics models will help elucidate complex disease pathogenesis, and
the predicted patterns in genetic data made by these models will enable the concurrent, more
comprehensive statistical testing of multiple aspects of disease genetics predictions, thereby better
Schrodi Theoretical Disease Genetics
identifying disease loci. By theoretical human genetics, I intend
to encompass all investigations devoted to modeling the heritable
architecture underlying disease traits and studies of the resulting
principles and dynamics of such models. Hence, the scope
of theoretical disease genetics work includes construction and
analysis of models describing how disease-predisposing alleles
(1) arise, (2) are transmitted across families and populations,
and (3) interact with other risk and protective alleles across
both the genome and environmental factors to produce disease
states. Theoretical work improves insight into viable genetic
models of diseases consistent with empirical results from linkage,
transmission, and association studies as well as population
genetics. Furthermore, understanding the patterns of genetic
data expected under realistic disease models will enable more
powerful approaches to discover disease-predisposing alleles
and additional heritable factors important in common diseases.
In spite of the pivotal role of disease genetics theory, such
investigation is not particularly vibrant. Currently, activities in
human disease genetics are primarily centered upon large-scale
empirical studies and, to a lesser extent, statistical methods, with
limited contribution to theory.
BACKGROUND AND FRAMEWORK
Broadly speaking, scientific progress is predicated on a robust
interplay between three activities: (1) empirical experimentation
and observation, (2) the development of theoretical models
and extraction of predicted patterns thereof, and (3) the
statistical evaluation of the probabilistic correspondence
between the predicted patterns and empirical data. Highly
impactful discoveries can certainly occur in the absence of
formalization of these activities, but these three aspects are
nonetheless critical. To exemplify, consider the relatively
recent remarkable finding of complex, low-level admixture
between modern humans and archaic humans (Green et al.,
2010; Reich et al., 2010; Gronau et al., 2011; Li and Durbin,
2011; Sankararaman et al., 2016). This discovery was made
through heroic efforts to isolate, sequence, assemble, and
align archaic DNA from Neanderthal and Denisovan remains.
In parallel, predictions of genetic architecture, divergence
patterns, and shared chromosomal regions from admixture
models were developed using both molecular phylogenetics
and population genetics theory involving mutation, genetic
drift, migration, and demographics. Lastly, correspondence
between the observed genetic data and theoretical predictions
were accomplished through a variety of likelihood-based,
Bayesian, and Fisherian approaches. It is not overreaching to
claim that this advance of our scientific knowledge hinged on
careful empirical observations/experiments, the development
of population genetics theory, and the formal evaluation of
rich theoretical predictions against observed data through
rigorous statistical methods. The most casual of observers will
note legions of additional examples of this paradigm from a
diverse set of scientific fields such as particle physics (Glashow,
1961; Higgs, 1964; Weinberg, 1967), mechanics (Einstein, 1916;
Schrodinger, 1926), enzyme kinetics (Michaelis and Menten,
1913), semiconductors (Hall, 1879; Wilson, 1931; Mott, 1938;
Schottky, 1938), atomic chemistry (Hund, 1926; Mulliken,
1932; Huckel, 1934), classical genetics (Mendel, 1866; Fisher,
1918), heredity and evolution (Fisher, 1930; Wright, 1932;
Price, 1970), population genetics (Hardy, 1908; Weinberg, 1908;
Hudson, 1982, 1983; Kingman, 1982a; Gillespie, 1993, 2000),
and predator-prey ecology (Lotka, 1925). Across these and
many other fields, theoretical work is a dynamic component
of the scientific process: unexplained empirical phenomena
motivate new theory, often in a relatively seamless manner,
and, conversely, predicted patterns stemming from mechanistic
models are digested by experimenters and promptly tested,
leading to an expeditious and efficient expansion in our
understanding of these phenomena.
Comparatively, disease gene mapping has grown a relatively
barren landscape of theory. Largely motivated by the desire to
impact clinical practice, human disease genetics has historically
been a highly pragmatic field where technological advancement
in genotyping and sequencing has spurred large-scale studies and
the bulk of quantitative work has focused on statistical methods
of analysis, rather than a more equitable partition of statistics
and theory. This has continued despite instances where profound
shifts in approaches have been driven by insights from theory. For
example, an extended stagnation in mapping common, complex
diseases was fractured by theoretical developments in the
mid- to late-1990s showing that high density genotyping using
population-based samples would have dramatically increased
power to detect high frequency disease-predisposing alleles of
moderate effect sizes, motivating the GWAS paradigm from an
overly-simplistic disease genetics model (Kaplan et al., 1995;
Risch and Merikangas, 1996; Long et al., 1997; Xiong and Guo,
1998; Kruglyak, 1999; Long and Langley, 1999).
Although not commonplace, there are other historical
examples of disease genetics theory driving accelerated progress
in human genetics, including the heterozygote selective
advantage theory of malaria and sickle-cell disease (Allison,
1954), that complex diseases do have a heritable component
(Steinberg et al., 1951; Pickering, 1978; Debray et al., 1979;
Kendler and Diehl, 1993; DeBraekeleer, 1991; Lynn et al.,
1995; Stein et al., 2005), that large multiplex families were
ideal for linkage studies of diseases under Mendelian disease
models (Thompson, 1978; Botstein et al., 1980), and the more
diffuse impact of theoretical ideas from population genetics
such as allele frequency spectra being highly skewed toward
very rare alleles (Ewens, 1972; Watterson, 1975; Slatkin and
Rannala, 1997; Long and Langley, 1999; Eyre-Walker, 2010;
Hudson, 2015)—accentuated in rapidly expanding populations,
haplotypes exhibiting block-like structure in LD patterns (Hill
and Robertson, 1968; Hudson and Kaplan, 1985; Nothnagel et al.,
2002; Wiuf and Posada, 2003), population bottlenecks followed
by expansion accentuates allelic dominance effects on fitness
(Balick et al., 2015), and alleles with deleterious effects on fitness
originating more recently than those neutral with respect to
fitness given the same allele frequency (Maruyama, 1974; Ziezun
et al., 2013). Theoretical work has been done on applying the
highly polygenic, additive model to common diseases, offering
some testable predictions (Yang et al., 2010, 2011a; Vinkhuyzen
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et al., 2013; Loh et al., 2015). Additional, useful efforts have
focused on widespread epistatic interactions (Hodge, 1981;
Neuman and Rice, 1992; Majewski et al., 2001; Zuk et al., 2012).
However, competing theoretical models of common disease
genetics are sparse even though both history and reason argue
for a more vigorous theoretician community and heightened
interaction between theory, experiment and statistical methods.
WHAT CONSTITUTES A USEFUL THEORY
OF DISEASE GENETICS?
Although many areas of investigation rightly fall under this
rubric, the general focus should be the development of testable
models that describe the set of heritable factors and interactions
that generate disease states. This includes allele and genotype
frequencies, numbers of susceptibility loci, numbers and types
of susceptibility alleles, penetrances, epistatic interactions,
properties of familial transmission, and effect modification with
environmental variables. It is important to draw a distinction
between the genetics that predispose an individual to a disease
and the genetic repertoire that underlies the predisposition to
a disease across a population of affected individuals, for we do
not know the extent in which each individual’s disease etiology
is unique for complex disease phenotypes. That is, although it
is well established from population-level analyses that complex
diseases are polygenic, we currently have little evidence that
definitively speaks to the level of allelic and locus heterogeneity
in any complex disease. What set of genotypes at a set of loci
are sufficient to generate disease in an individual? What is the
variation in these disease-predisposing sets of genotypes and
loci across diseased individuals? Do the alleles co-segregate with
disease states across relatedness structures? Coherent, useful
theories of disease genetics must address these questions.
Theoretical population genetics, with numerous practitioners
using coalescent theory and similar tools to study the
maintenance of alleles in populations and elucidate the
evolutionary forces responsible for genetic variation, is relatively
advanced (Kaplan et al., 1988; Hudson, 1991; Charlesworth
et al., 1997; Calafell et al., 2001). As population genetics
is concerned with the dynamics and distributions of alleles
in populations (Ewens, 1972; Moran, 1975; Watterson, 1975;
Kingman, 1982a,b; Charlesworth and Jain, 2014; Greenbaum,
2015), the relevance of population genetics theory to disease gene
mapping—particularly for case-control association studies, fine-
scalemapping, and population stratification—is undeniably clear,
with several important advances demonstrating applicability
(Pritchard et al., 2000; Morris et al., 2002; Molitor et al., 2003;
Burkett et al., 2014). However, population genetics theory, in and
of itself, is inadequate to serve as a complete theory for modeling
the disease genetics: (1) coalescent theory is largely concerned
with samples of random chromosomes from a population, rather
than from disease-affected individuals; (2) there is limited focus
on the treatment of related individuals; (3) whereas population
genetics aims to delineate the relative impact of natural selection,
genetic drift, mutation and demographic effects, diseases have a
complex, enigmatic relationship to fitness—some diseases may
result from mutation-selection balance, other diseases may carry
susceptibility genes that are neutral with respect to selection,
while some disease genes may be subjected to directional
selection, and many diseases, such as type 2 diabetes (Hu,
2011), may result from a shift to a modern environment; (4)
theoretical population genetics concentrates on the dynamics
of individual loci in isolation; and (5) somatic mutations and
heritable epigenetic factors, which play important roles in at least
some common diseases, are often not the subject of mainstream
population genetics theory.
Similarly, the theoretical models from quantitative genetics
are also problematic in their direct applicability to investigations
of disease genetics architecture. These models are almost
exclusively direct derivatives of the infinitely polygenic, miniscule
additive effects model (IPMAE model) (Falconer and MacKay,
1996; Frank, 2011). Often, when applied to a dichotomous
outcome, a threshold (Wright, 1934) or liability function
(Falconer, 1965; Curnow and Smith, 1972) is overlaid on the
IPMAE model. Historically, work on the IPMAE model was
designed for the study of quantitative traits, such as livestock
lean body weight and crop yield, in agriculturally important
organisms and specifically-designed pedigrees to assess measures
such as breeding values (Falconer and MacKay, 1996; Lynch and
Walsh, 1998). Although this model carries utility for analysis
of quantitative traits in general populations, and the application
to human disease is strongly argued by some (Hill et al., 2008;
Plomin et al., 2009), whether or not the coupling of a liability
function with the IPMAE model is indeed the appropriate model
of allelic architecture for any dichotomous complex disease
is currently unknown. Many, if not most disease physiologies
are fundamentally different than naturally-occurring phenotype
variation investigated by quantitative geneticists, and it is
reasonable to assume that their underlying allelic architecture
also differs. Recently, several have strongly argued against the
continued use of the IPMAE model for the purpose of dissecting
complex diseases (Nelson et al., 2013; Génin and Clerget-
Darpoux, 2015). Although I personally favor models other than
the IPMAE model for complex diseases, I do not think that
either theoretical nor empirical evidence is currently sufficient to
completely dismiss the IPMAE model. It is certainly possible, a
priori, that tens or hundreds of thousands loci across the genome
harbor alleles of very small effect sizes, all marginally contributing
to additively increase disease risk. Moreover, many types of
models may appear to have additive and nearly independent
effects as those effect sizes become small. If complex diseases
are a conglomeration of distinct physiological entities with their
own genetic etiologies, erroneously aggregated by physicians,
it appears possible that the IPMAE model may be reasonable,
at least for interpreting data from population-based studies.
If molecular networks are highly redundant and numerous
pathogenic changes are necessary to compromise the function
of these networks, then the IPMAE model might be appropriate.
So, rather than disbanding the IPMAE model entirely, a prudent
direction would be encouraging the development of alternative
theoretical models. A competitive marketplace of disease genetics
models is a critically important cog in the unraveling the
genetic architecture of all diseases. Certainly, the correspondence
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between IPMAE predictions and experimental data will be
the ultimate arbitrator. Empirically, the jury is mixed with
some studies offering moderate evidence of consistency between
genetic association data and the IPMAE model (Yang et al.,
2010, 2011a; Vinkhuyzen et al., 2013; Bulik-Sullivan et al., 2015;
Loh et al., 2015), while others do not (Ritchie et al., 2001;
Kirino et al., 2013; Ridge et al., 2013; Fritsche et al., 2014),
and familial data has yet to definitively support or refute the
model. Of note, a useful global measure of the magnitude
of polygenic inheritance has been discussed by Yang et al.
(2011b). Interestingly, testing polygenetic architecture models
on GWAS data for four complex diseases—rheumatoid arthritis,
celiac disease, myocardial infarction/coronary artery disease,
and type 2 diabetes—using Bayesian Approximate Computation,
Stahl and colleagues estimated the joint density of the number
of independent disease-predisposing SNPs and the liability-
scale variance explained showing consistency with models using
roughly 2000 SNPs (Stahl et al., 2012).
Within human genetics, the majority of models of common
disease genetic architecture used in practice fall into two overly-
simplistic camps: (1) monogenic and two-locus models with
a biallelic markers and typically one of four classical modes
of inheritance (fully dominant, fully recessive, additive, or
multiplicative), and (2) direct derivatives of the IPMAE model.
One only has to go as far as to look at commonly-used
power calculators for genetic association or linkage studies to
observe this rather ubiquitous, long-standing, yet fairly impotent
state of affairs. Parametric linkage studies using monogenic
models produced spurious results for complex diseases (Génin
and Clerget-Darpoux, 2015). Much of their use has resulted
from convenience—both the monogenic/two-locus models and
the IPMAE model are mathematically tractable and other,
more realistic models may necessitate complex mathematical
treatment or computational approaches. Not only do these two
classes of models represent the ends of a wide spectrum of
models, but this limited number of disease genetics models is
symptomatic of an anemic theoretical effort. That said, what we
have learned about the properties and dynamics of the IPMAE
(Blangero et al., 2013; Zhou et al., 2013) and monogenic/two-
locus models (Li and Reich, 2000; Zaykin et al., 2006; Schrodi
et al., 2007; Zaykin and Shibata, 2008) will serve us well for the
development of the next generation of theoretical disease genetics
models. For example, the finite, additive polygenic model relaxes
from the extremely large number of disease loci assumption of
the IPMAE (Cannings et al., 1978; Lange, 1997). Further, new
statistical approaches, explicitly harnessing theoretical models
of polygenic inheritance to better understand genetic variation
of complex traits are starting to be developed (Zhou et al.,
2013). In my view, finite rare allele models of moderately
high effect sizes, high allelic, and high locus heterogeneity with
effect modification by genetic background deserve attention.
Importantly, very recent results from simulations appear to
favor incomplete recessivity models for complex trait etiologies,
demonstrating consistency with both realistic population genetic
models, heritability data, and GWAS findings (Sanjak et al.,
2016). Such work suggests prioritizing tests of recessive modes
of inheritance and compound heterozygosity testing for common
disease mapping.
While it is undeniable that substantial biological insights
and clinical utility have resulted from identifying alleles
truly associated/linked with complex diseases (Sabbagh and
Darlu, 2006; Roychowdhury and Chinnaiyan, 2013; Bottini
and Peterson, 2014; Kavanaugh et al., 2014; Everett et al.,
2015; Lueck et al., 2015), we are currently in the infancy of
understanding disease genetics where prediction of any common,
complex disease is not yet clinically practicable (Schrodi et al.,
2014), and efficacious, highly targeted therapies are sparse. One
bright point for disease prediction, borrowed from quantitative
genetics and work on highly polygenic additive models, is
the use of best linear unbiased prediction (BLUP) (Speed
and Balding, 2014; Vilhjalmsson et al., 2015). That said, the
overall lack of realistic theoretical models dramatically hinders
our progress, for powerful experimental designs and analysis
techniques could be optimized to suit the predictions of such
models. Yet the tools are available to make significant theoretical
inroads. Data processing approaches (Fan et al., 2014) and
machine learning has become incorporated into development
of genetic models and their evaluation (Libbrecht and Noble,
2015). Graphical modeling programming software are well-
developed (Hall et al., 2009). In addition, the investigation
and use of causal models may also advance human genetics
theory (Pearl, 2000; Madsen et al., 2011a,b). Fast Markov-
chain-Monte-Carlo algorithms to screen complicated, vast
parameter spaces are accessible. And, most importantly, the
accumulated results from multiplex linkage studies, affected
sibling pair studies, studies assessing disease concordance
between relative pairs of varying relatedness, twin studies,
family-based transmission/disequilibrium studies, GWAS, and
familial and population-based sequencing studies are available.
Moreover, high-throughput genotyping and sequencing have
painted a detailed picture of the raw materials from which
disease genetics are sampled: the allele frequency spectrum
and LD patterns. Disease genetics models must be consistent
with these results. Ideally, an abundant assortment of viable
theoretical disease genetics models will be developed, generating
informative, distinguishing predictions. These predictions can
then be tested against the accumulated patterns of genetic data,
producing posterior probabilities, or likelihoods for each model.
As the empirical data accumulates, the posterior probability
density across the parameter space of the models will indicate
those models with reasonably high posterior probabilities, with
many models being ruled out. Not only would such work
illuminate plausible etiological models of complex diseases,
but it would suggest highly-powered experimental designs and
statistical methods. In particular, with the determination of likely
disease genetics models, one could harness a variety of predicted
patterns to improve the discovery and assessment of casual loci.
A more detailed example may provide additional weight
and clarity to this argument. Consider a standard common
disease case/control GWAS study. With notable exceptions of
issues such as clustering of subjects using dimensional reduction
methods (Price et al., 2006), most such studies are designed and
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analyzed to solely test the simple hypothesis of independence
between disease status and genotype frequencies at single sites.
However, formal disease genetics models could offer a wealth
of predictions concerning genetic architecture patterns in the
data: (1) Diseases with early onset and probable ancestral effects
on fitness predict selection against disease-predisposing alleles
which would generate departures from neutrality as measured
by metrics such as Tajima’s (1989). (2) Departures from Hardy-
Weinberg Equilibrium differ between cases and controls under
several disease models (Nielsen et al., 1999). (3) The linkage
disequilibrium patterns within cases at the susceptibility locus
are expected to differ from those patterns observed in controls
(Zaykin et al., 2006; Schrodi et al., 2007; Pan, 2010). (4) The
decay of disease association with declining linkage disequilibrium
between a causal site and closely-linked markers follows a
particular form (Lai et al., 1994; Pritchard and Przeworski,
2001; Garcia et al., 2008; Schrodi et al., 2009; Maadooliat et al.,
2016). (5) Cases are expected to exhibit increased sharing of
chromosomal segments compared to controls (Houwen et al.,
1994; Te Meerman et al., 1995; Browning and Thompson,
2012). (6) Models generating allelic heterogeneity such as
the rare allele/large effect (RALE) model suggest investigating
multiple predisposing sequence variants segregating at each
gene/functional motif (Personal communication with RayWhite,
2000-2010; Terwilliger and Göring, 2000; Pritchard, 2001;
Thornton et al., 2013) and perhaps testing for linkage. Little
imagination is necessary to presume that additional, highly useful
predicted genetic patterns exist under disease genetics models,
hereto underutilized. So long as the disease genetics model is
sufficiently accurate or the predictions are robust across models,
concurrently testing the rich panoply of theoretical predictions
extracts increased information, enabling more refined, credible,
and localized discovery of pathogenic alleles. Notably, Agarwala
and colleagues have conducted excellent work in this area for type
2 diabetes (Agarwala et al., 2013). They have used a combination
of simulation results and results from affected sibling linkage
studies, GWAS, a polygenic score logistic regression, and
sequencing studies to reduce the model space of possible
architecture models. They foresee further reduction in the
space of possible models being dependent on the findings from
very large-scale sequencing studies. I applaud this considerable
effort and hope that further work in this area is strongly
supported.
There are similar implications for such theoretical disease
genetics when applied to family-based studies. Predictions
from realistic disease genetics models enable the coherent
exploration of critical questions such as (1) Is the distribution
of chromosomal regions shared by affected individuals indicative
of disease loci? (2) Are the observed phenotypic variance within
families and familial aggregation patterns consistent with specific
disease genetics models? (3) Are the transmission patterns
within families consistent with disease genetics models? And
(4) Given a specific disease genetics model, what is the optimal
size of family structure for finding chromosomal regions linked
and associated with complex diseases (i.e., siblings, multiplex
families, founder populations, or general populations)? Just as
with population-based studies, the development of theoretical
models of disease genetics illuminates the path to jointly testing
numerous observed genetic patterns within familial structures.
Wray and Goddard have started to explore some of these issues
and have shown that three disease models are roughly consistent
with data on disease risk in relatives (Wray and Goddard, 2010).
RELATED AREAS OF THEORY
DEVELOPMENT
One area of active research that would profit from the
advancement of disease genetics theory is the development
of fine mapping methods to identify causal variants within a
disease-associated region. Discovering causal variants is critically
important for several reasons, most notably that expensive, time-
consuming, follow-up laboratory experiments are predicated on
which gene or functional motif are indicted by the genetic
evidence. This problem of identifying disease-causing variants
in regions of often complex linkage disequilibrium patterns
and allelic heterogeneity, although dramatically understudied
in the past, has now been increasingly recognized as being
vital in the human genetics toolbox. One example is the
fine-mapping method of Maller and colleagues which uses a
ranked set of Bayes factors (one for each polymorphism in an
associated region) (Wellcome Trust Case Control Consortium
et al., 2012). Other approaches include Bim-Bam (Servin and
Stephens, 2007), CAVIAR (Hormozdiari et al., 2014), CAVIARBF
(Chen et al., 2015), coalescent-based methods (Graham,
1998; Morris et al., 2002; Zollner and Pritchard, 2005), and
PAINTOR (Kichaev et al., 2014), which incorporates functional
information probabilistically. While I applaud these excellent,
thoughtful methods, as a generalization these approaches are
statistically appropriate and easily interpretable, but use overly
simplistic disease genetics models. If we held a more complete
understanding of the theoretical properties of alleles that underlie
complex diseases and their correlation patterns with linked
variants, one could incorporate this information into more
powerful fine mapping methods.
Aside from the need for the development and analysis of
DNA-based models of disease predisposition, similar models of
other heritable factors involved in pathogenesis such as inherited
RNA pools, histone acetylation, and DNA methylation effects
are essential for the rapid advancement of disease genetics. It
is becoming increasingly clear that epigenetic factors play a
role in heritable diseases (Uddin et al., 2010; Williams et al.,
2010; Allum et al., 2015; Montano et al., 2016). However, just
as clear is the near absence of theoretical models describing
epigenetics as an etiological factor in diseases. Several simple
questions need investigation: What are the probabilistic laws
that govern the transmission of these epigenetic factors? That is,
what is the distribution of probabilities that a given epigenetic
state is transmitted to a subsequent generation? How do these
probabilities attenuate across multiple generations? What are the
frequencies of various epigenetic changes and the corresponding
effects on disease risk? What is the fraction of an individual’s
disease risk that is generated by epigenetic changes? And how
is this fraction distributed across a population? Development
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of these theoretical models will allow for the calculation of
testable predictions and aid in the construction of more powerful
experimental designs.
CONCLUSION
To be balanced, there certainly are efforts in human genetics
theory, several of which have been discussed, enabling statistical
methods that harness informative theoretical predictions (Reich
and Lander, 2001; Zhu et al., 2015). The crux of the argument
made here, however, is one of degree: Additional training of
human geneticists in theoretical models, complementing, and
motivating statistical methods, would be beneficial. Additional
construction of disease genetics models to evaluate against
empirical data is vitally needed. Additional work on identifying
the patterns of genetic data expected under theoretical models
is essential. Additional evaluation of empirical data from large
multiplex families, affected sibling pairs, isolated populations,
founder populations, transmission-based tests, GWAS, whole
genome/exome sequencing studies in families, and population-
based sequencing studies to determine which disease models are
supported and which can be excluded based on these results
would be highly productive. And additional interplay between
theory, experiment, and analysis is critical. My central thesis is
that funding and effort must be balanced in a way that produces
complementarily functioning triad of theory, experiment, and
statistics, so that the entire field of human genetics moves
forward unabated. Currently, experimental studies and statistical
methods are clearly active and highly-functioning subfields,
whereas, the field has a dearth of theoretical disease genetics
models, impeding the entire disease gene mapping enterprise.
The timing is ideal for the institution of these changes. We
have amassed vast amounts of genetic data for many hundreds
of common diseases and rarer, related conditions and yet
the heritable causes of each common disease remain poorly
understood. Colossal, expensive shifts in focus have been
historically driven by simplistic, undeveloped theoretical models,
e.g., common disease/common variant hypothesis (Reich and
Lander, 2001), so it may be more fruitful for our field to
further develop resources and capabilities that generate more
fully developed theoretical models of disease genetics. Perhaps it
is time for a new field of theoretical disease genetics.
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